Welcome to Wopular's coverage of Hostile Bid, Genzyme.
Wopular aggregates news headlines from the top newspapers and
news sources. To the right are articles about
Hostile Bid, Genzyme that have been featured on main sections
of the site.
Below are topics about Hostile Bid, Genzyme. (Click on "all"
to view all articles related to the topic, including articles NOT about
Hostile Bid, Genzyme.
French drugmaker Sanofi-Aventis launched a hostile bid for Genzyme at $69 per share on Monday, taking its $18.5 billion offer direct to shareholders after Genzyme management refused to negotiate.